scholarly article | Q13442814 |
P50 | author | Lourdes Rodriguez Fragoso | Q71892259 |
P2093 | author name string | Jorge Reyes-Esparza | |
Francisco García-Vázquez | |||
Antonieta Gómez-Solís | |||
Elizabeth Alvarez-Ayala | |||
P2860 | cites work | From observation to experimentation: leptin action in the mediobasal hypothalamus | Q24644953 |
Inflammation and metabolic disorders | Q27860923 | ||
Obesity is associated with macrophage accumulation in adipose tissue | Q27860976 | ||
Origin and physiological roles of inflammation | Q29614298 | ||
Adipose tissue as an endocrine organ | Q29620407 | ||
Metabolic syndrome pandemic. | Q30366941 | ||
Effect of fructooligosaccharides fraction from Psacalium decompositum on inflammation and dyslipidemia in rats with fructose-induced obesity. | Q30746231 | ||
Deletion of Fas in adipocytes relieves adipose tissue inflammation and hepatic manifestations of obesity in mice | Q33559605 | ||
Obesity and its metabolic complications: the role of adipokines and the relationship between obesity, inflammation, insulin resistance, dyslipidemia and nonalcoholic fatty liver disease | Q33580624 | ||
Relationship between obesity, adipocytokines and inflammatory markers in type 2 diabetes: relevance for cardiovascular risk prevention | Q33627732 | ||
FXR activation reverses insulin resistance and lipid abnormalities and protects against liver steatosis in Zucker (fa/fa) obese rats | Q33741191 | ||
Fat: a matter of disturbance for the immune system. | Q34200814 | ||
Monocyte chemoattractant protein 1 in obesity and insulin resistance | Q35163496 | ||
Human fatty liver disease: old questions and new insights | Q35588477 | ||
Peptides and their potential role in the treatment of diabetes and obesity | Q35760298 | ||
Leptin, from fat to inflammation: old questions and new insights. | Q36005249 | ||
Adipose tissue, inflammation, and cardiovascular disease | Q36125401 | ||
Endothelial and erectile dysfunction, diabetes mellitus, and the metabolic syndrome: common pathways and treatments? | Q36357659 | ||
The metabolic syndrome: inflammation, diabetes mellitus, and cardiovascular disease | Q36380101 | ||
Recent advances in the relationship between obesity, inflammation, and insulin resistance. | Q36448850 | ||
Adipose tissue and adipokines--energy regulation from the human perspective. | Q36506049 | ||
Effect of obesity reduction on preservation of heart function and attenuation of left ventricular remodeling, oxidative stress and inflammation in obese mice | Q36552526 | ||
Obesity and nonalcoholic fatty liver disease: biochemical, metabolic, and clinical implications | Q36617551 | ||
Antidiabetic treatment restores adiponectin serum levels and APPL1 expression, but does not improve adiponectin-induced vasodilation and endothelial dysfunction in Zucker diabetic fatty rats | Q36711237 | ||
Relation of serum cytokine concentrations to cardiovascular risk factors and coronary heart disease | Q36847941 | ||
Non-alcoholic fatty liver disease and the metabolic syndrome: an update | Q37054351 | ||
Sitagliptin prevents aggravation of endocrine and exocrine pancreatic damage in the Zucker Diabetic Fatty rat - focus on amelioration of metabolic profile and tissue cytoprotective properties | Q37720797 | ||
Physiological, pathological and potential therapeutic roles of adipokines. | Q38007838 | ||
Antiapoptotic effect of a novel synthetic peptide from bovine muscle and MPG peptide on H2O2-induced C2C12 cells | Q38995239 | ||
Lipopolysaccharides accelerate hepatic steatosis in the development of nonalcoholic fatty liver disease in Zucker rats | Q41853980 | ||
Effect of synthetic thymic humoral factor (THF-gamma 2) on T cell activities in immunodeficient ageing mice | Q42002571 | ||
Obesity phenotype is related to NLRP3 inflammasome activity and immunological profile of visceral adipose tissue. | Q42271438 | ||
Prevalence and correlates of metabolic syndrome based on a harmonious definition among adults in the US. | Q42869469 | ||
Isolation of bovine thymin: a polypeptide hormone of the thymus | Q43735353 | ||
Insulin and Obesity in the Zucker Genetically Obese Rat “Fatty” | Q43740934 | ||
A hypercaloric pellet-diet cycle induces obesity and co-morbidities in Wistar rats | Q46344079 | ||
Noradrenaline-mediated inhibition of inflammatory cytokines is altered in macrophages from obese Zucker rats: effect of habitual exercise | Q46438686 | ||
Heme oxygenase-mediated increases in adiponectin decrease fat content and inflammatory cytokines tumor necrosis factor-alpha and interleukin-6 in Zucker rats and reduce adipogenesis in human mesenchymal stem cells | Q46707414 | ||
Thymopentin and splenopentin as immunomodulators. Current status | Q47933330 | ||
Plasma Adiponectin in Patients with Active, Early, and Chronic Rheumatoid Arthritis Who Are Steroid- and Disease-Modifying Antirheumatic Drug-Naive Compared with Patients with Osteoarthritis and Controls | Q56974092 | ||
T-ing up inflammation in fat | Q58197131 | ||
Pharmacological evaluation of the immunomodulatory FL-6 in induced chronic hepatitis in Wistar rats | Q61895681 | ||
Immune modulation exerted by thymic humoral factor (THF-gamma 2), on T-cell subsets and IL-2 production of umbilical cord blood lymphocytes | Q67296152 | ||
Supraphysiological triiodothyronine doses diminish leptin and adiponectin gene expression, but do not alter resistin expression in calorie restricted obese rats | Q84071353 | ||
Serum interferon gamma concentration is associated with bone mineral density in overweight boys | Q87233760 | ||
Cardio-adipose tissue cross-talk: relationship between adiponectin, plasma pro brain natriuretic peptide and incident heart failure | Q87661825 | ||
P433 | issue | 3 | |
P921 | main subject | obesity | Q12174 |
P304 | page(s) | 172-181 | |
P577 | publication date | 2014-09-01 | |
P1433 | published in | International Journal of Biomedical Science | Q26842285 |
P1476 | title | Immuno-modulator metallo-Peptide reduces inflammatory state in obese zucker fa/fa rats | |
P478 | volume | 10 |
Search more.